Losartan Market 2028 By Indication, Route of Administration and Geography | The Insight Partners

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Losartan Market - By Indication
1.3.2 Losartan Market - By Route of Administration
1.3.3 Losartan Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. LOSARTAN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. LOSARTAN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. LOSARTAN MARKET - GLOBAL MARKET ANALYSIS
6.1. LOSARTAN - GLOBAL MARKET OVERVIEW
6.2. LOSARTAN - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. LOSARTAN MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
7.1. OVERVIEW
7.2. INDICATION MARKET FORECASTS AND ANALYSIS
7.3. BLOOD PRESSURE
7.3.1. Overview
7.3.2. Blood Pressure Market Forecast and Analysis
7.4. STROKE
7.4.1. Overview
7.4.2. Stroke Market Forecast and Analysis
7.5. HEART DISEASE
7.5.1. Overview
7.5.2. Heart Disease Market Forecast and Analysis
8. LOSARTAN MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis

9. LOSARTAN MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Losartan Market Overview
9.1.2 North America Losartan Market Forecasts and Analysis
9.1.3 North America Losartan Market Forecasts and Analysis - By Indication
9.1.4 North America Losartan Market Forecasts and Analysis - By Route of Administration
9.1.5 North America Losartan Market Forecasts and Analysis - By Countries
9.1.5.1 United States Losartan Market
9.1.5.1.1 United States Losartan Market by Indication
9.1.5.1.2 United States Losartan Market by Route of Administration
9.1.5.2 Canada Losartan Market
9.1.5.2.1 Canada Losartan Market by Indication
9.1.5.2.2 Canada Losartan Market by Route of Administration
9.1.5.3 Mexico Losartan Market
9.1.5.3.1 Mexico Losartan Market by Indication
9.1.5.3.2 Mexico Losartan Market by Route of Administration
9.2. EUROPE
9.2.1 Europe Losartan Market Overview
9.2.2 Europe Losartan Market Forecasts and Analysis
9.2.3 Europe Losartan Market Forecasts and Analysis - By Indication
9.2.4 Europe Losartan Market Forecasts and Analysis - By Route of Administration
9.2.5 Europe Losartan Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Losartan Market
9.2.5.1.1 Germany Losartan Market by Indication
9.2.5.1.2 Germany Losartan Market by Route of Administration
9.2.5.2 France Losartan Market
9.2.5.2.1 France Losartan Market by Indication
9.2.5.2.2 France Losartan Market by Route of Administration
9.2.5.3 Italy Losartan Market
9.2.5.3.1 Italy Losartan Market by Indication
9.2.5.3.2 Italy Losartan Market by Route of Administration
9.2.5.4 Spain Losartan Market
9.2.5.4.1 Spain Losartan Market by Indication
9.2.5.4.2 Spain Losartan Market by Route of Administration
9.2.5.5 United Kingdom Losartan Market
9.2.5.5.1 United Kingdom Losartan Market by Indication
9.2.5.5.2 United Kingdom Losartan Market by Route of Administration
9.2.5.6 Rest of Europe Losartan Market
9.2.5.6.1 Rest of Europe Losartan Market by Indication
9.2.5.6.2 Rest of Europe Losartan Market by Route of Administration
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Losartan Market Overview
9.3.2 Asia-Pacific Losartan Market Forecasts and Analysis
9.3.3 Asia-Pacific Losartan Market Forecasts and Analysis - By Indication
9.3.4 Asia-Pacific Losartan Market Forecasts and Analysis - By Route of Administration
9.3.5 Asia-Pacific Losartan Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Losartan Market
9.3.5.1.1 Australia Losartan Market by Indication
9.3.5.1.2 Australia Losartan Market by Route of Administration
9.3.5.2 China Losartan Market
9.3.5.2.1 China Losartan Market by Indication
9.3.5.2.2 China Losartan Market by Route of Administration
9.3.5.3 India Losartan Market
9.3.5.3.1 India Losartan Market by Indication
9.3.5.3.2 India Losartan Market by Route of Administration
9.3.5.4 Japan Losartan Market
9.3.5.4.1 Japan Losartan Market by Indication
9.3.5.4.2 Japan Losartan Market by Route of Administration
9.3.5.5 South Korea Losartan Market
9.3.5.5.1 South Korea Losartan Market by Indication
9.3.5.5.2 South Korea Losartan Market by Route of Administration
9.3.5.6 Rest of Asia-Pacific Losartan Market
9.3.5.6.1 Rest of Asia-Pacific Losartan Market by Indication
9.3.5.6.2 Rest of Asia-Pacific Losartan Market by Route of Administration
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Losartan Market Overview
9.4.2 Middle East and Africa Losartan Market Forecasts and Analysis
9.4.3 Middle East and Africa Losartan Market Forecasts and Analysis - By Indication
9.4.4 Middle East and Africa Losartan Market Forecasts and Analysis - By Route of Administration
9.4.5 Middle East and Africa Losartan Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Losartan Market
9.4.5.1.1 South Africa Losartan Market by Indication
9.4.5.1.2 South Africa Losartan Market by Route of Administration
9.4.5.2 Saudi Arabia Losartan Market
9.4.5.2.1 Saudi Arabia Losartan Market by Indication
9.4.5.2.2 Saudi Arabia Losartan Market by Route of Administration
9.4.5.3 U.A.E Losartan Market
9.4.5.3.1 U.A.E Losartan Market by Indication
9.4.5.3.2 U.A.E Losartan Market by Route of Administration
9.4.5.4 Rest of Middle East and Africa Losartan Market
9.4.5.4.1 Rest of Middle East and Africa Losartan Market by Indication
9.4.5.4.2 Rest of Middle East and Africa Losartan Market by Route of Administration
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Losartan Market Overview
9.5.2 South and Central America Losartan Market Forecasts and Analysis
9.5.3 South and Central America Losartan Market Forecasts and Analysis - By Indication
9.5.4 South and Central America Losartan Market Forecasts and Analysis - By Route of Administration
9.5.5 South and Central America Losartan Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Losartan Market
9.5.5.1.1 Brazil Losartan Market by Indication
9.5.5.1.2 Brazil Losartan Market by Route of Administration
9.5.5.2 Argentina Losartan Market
9.5.5.2.1 Argentina Losartan Market by Indication
9.5.5.2.2 Argentina Losartan Market by Route of Administration
9.5.5.3 Rest of South and Central America Losartan Market
9.5.5.3.1 Rest of South and Central America Losartan Market by Indication
9.5.5.3.2 Rest of South and Central America Losartan Market by Route of Administration

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. LOSARTAN MARKET, KEY COMPANY PROFILES
11.1. TORRENT PHARMACEUTICALS
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. MACLEODS PHARMACEUTICALS
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. MERCK
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. TEVA PHARMACEUTICALS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. LUPIN
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. CIPLA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SANDOZ
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SUN PHARMACEUTICALS
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. UNICHEM LABORATORIES
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. DR. REDDY'S LABORATORIES
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS